Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

APREA THERAPEUTICS, INC.

(APRE)
  Report
Delayed Quote. Delayed Nasdaq - 10/15 04:00:01 pm
5.14 USD   -3.93%
10/15APREA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/05INSIDER SELL : Aprea Therapeutics
MT
09/22INSIDER SELL : Aprea Therapeutics
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about APREA THERAPEUTICS, INC.
10/05INSIDER SELL : Aprea Therapeutics
MT
09/22INSIDER SELL : Aprea Therapeutics
MT
09/20APREA THERAPEUTICS : Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advan..
AQ
09/20Aprea Therapeutics, Inc. Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) i..
CI
09/20APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from S&P Global BMI Index
CI
09/14APREA THERAPEUTICS : to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Soli..
AQ
09/14Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Sol..
CI
08/20APREA THERAPEUTICS : JPMorgan Downgrades Aprea Therapeutics to Underweight From Neutral
MT
08/16APREA THERAPEUTICS : HC Wainwright Adjusts Aprea Therapeutics' Price Target to $4 from $6,..
MT
08/16APREA THERAPEUTICS : Berenberg Bank Downgrades Aprea Therapeutics to Hold From Buy Followi..
MT
08/13APREA THERAPEUTICS : RBC Cuts Price Target on Aprea Therapeutics to $5 From $6 Amid FDA Ho..
MT
08/13APREA THERAPEUTICS : Morgan Stanley Lowers Aprea Therapeutics to Underweight From Equal-We..
MT
08/12APREA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Update on ..
PU
08/12Aprea Therapeutics, Inc. Reports Unaudited Consolidated Earnings Results for the Second..
CI
08/12Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on..
GL
More most relevant news
All news about APREA THERAPEUTICS, INC.
10/15APREA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/05INSIDER SELL : Aprea Therapeutics
MT
09/22INSIDER SELL : Aprea Therapeutics
MT
09/20APREA THERAPEUTICS : Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advan..
AQ
09/20Aprea Therapeutics, Inc. Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) i..
CI
09/20Top Premarket Gainers
MT
09/20APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from S&P Global BMI Index
CI
09/14APREA THERAPEUTICS : to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Soli..
AQ
09/14Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Sol..
CI
08/23NORTH AMERICAN MORNING BRIEFING : Stock Furures -3-
DJ
More news
News in other languages on APREA THERAPEUTICS, INC.
10/05VENTE PAR DES INITIÉS : Aprea Therapeutics
09/22VENTE PAR DES INITIÉS : Aprea Therapeutics
More news
Analyst Recommendations on APREA THERAPEUTICS, INC.
08/20APREA THERAPEUTICS : JPMorgan Downgrades Aprea Therapeutics to Underweight From Neutral
MT
08/16APREA THERAPEUTICS : HC Wainwright Adjusts Aprea Therapeutics' Price Target to $4 from $6,..
MT
08/16APREA THERAPEUTICS : Berenberg Bank Downgrades Aprea Therapeutics to Hold From Buy Followi..
MT
08/13APREA THERAPEUTICS : RBC Cuts Price Target on Aprea Therapeutics to $5 From $6 Amid FDA Ho..
MT
08/13APREA THERAPEUTICS : Morgan Stanley Lowers Aprea Therapeutics to Underweight From Equal-We..
MT
More recommendations
Press releases
10/15APREA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/20APREA THERAPEUTICS : Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advan..
AQ
09/14APREA THERAPEUTICS : to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Soli..
AQ
08/12APREA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/12APREA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Update on ..
PU
More press releases
Upcoming event on APREA THERAPEUTICS, INC.